Dashboard
Manage Tickers

NEPHNEPHROS INC

Nasdaq nephros.com


$ 2.39 $ 0.09 (3.97 %)    

Friday, 17-May-2024 13:21:32 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 2.36
$ 2.39
$ 0.00 x 0
$ 0.00 x 0
$ 2.39 - $ 2.39
$ 1.16 - $ 4.04
60,155
na
24.78M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-15-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-20-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-10-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-15-2015 03-31-2015 10-Q
38 04-15-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benchmark-reiterates-speculative-buy-on-nephros-maintains-5-price-target
Benchmark Reiterates Speculative Buy on Ne...
05/15/2024 11:56:15

Benchmark analyst Robert Wasserman reiterates Nephros (NASDAQ:NEPH) with a Speculative Buy and maintains $5 price target.

nephros-files-for-mixed-shelf-of-up-to-50m
Nephros Files For Mixed Shelf Of Up To $50M
05/10/2024 20:31:43

-SEC Filing

nephros-q1-2024-gaap-eps-002-beats-004-estimate-sales-3522m-miss-3734m-estimate
Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0...
05/09/2024 21:44:19

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50...

benchmark-upgrades-nephros-to-speculative-buy-announces-5-price-target
Benchmark Upgrades Nephros to Speculative ...
03/08/2024 18:46:43

Benchmark analyst Robert Wasserman upgrades Nephros (NASDAQ:NEPH) from Hold to Speculative Buy and announces $5 price target.

nephros-q4-earnings-insights
Nephros: Q4 Earnings Insights
03/07/2024 21:45:17

nephros-q4-2023-gaap-eps-0060-misses-0030-estimate-sales-3300m-miss-3813m-estimate
Nephros Q4 2023 GAAP EPS $(0.060) Misses $...
03/07/2024 21:42:25

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.030) b...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

earnings-outlook-for-nephros
Earnings Outlook For Nephros
03/06/2024 18:02:29

11-consumer-discretionary-stocks-moving-in-mondays-intraday-session
11 Consumer Discretionary Stocks Moving In...
02/26/2024 17:31:12

12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
12/26/2023 17:31:15

why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Despegar.com Shares Are Trading Higher...
12/13/2023 18:40:34

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
12/12/2023 17:31:17

insiders-buying-delcath-systems-and-3-other-penny-stocks
Insiders Buying Delcath Systems And 3 Othe...
12/12/2023 13:21:28

The Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confi...

nephros-q3-earnings-insights
Nephros: Q3 Earnings Insights
11/08/2023 21:50:23

nephros-q3-eps-002-beats-006-estimate-sales-374m-beat-335m-estimate
Nephros Q3 EPS $(0.02) Beats $(0.06) Estim...
11/08/2023 21:49:16

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.06) by 66...

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

nephros-names-judy-krandel-as-cfo-effective-today
Nephros Names Judy Krandel As CFO, Effecti...
11/01/2023 11:36:20

12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
09/26/2023 17:31:08

12-consumer-discretionary-stocks-moving-in-thursdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
08/10/2023 17:31:10

nephros-q2-eps-004-beats-005-estimate-sales-354m-beat-311m-estimate
Nephros Q2 EPS $(0.04) Beats $(0.05) Estim...
08/09/2023 20:20:39

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION